Atlas Trials

Dual-Orexin Antagonism As a Mechanism for Improving Sleep and Drug Abstinence in Opioid Use Disorder

Clinical trial NCT04262193 · TERMINATED

Trial details

NCT number
NCT04262193
Sponsor
Wayne State University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Opioid-use DisorderSleep
Start date
2021-02-01
Primary completion
2024-07-30
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.